One of the most beloved candy makers in the world is promising to invest billions into the United States economy.
The company responsible for confectionery favorites like M&M’s and Skittles is pledging an additional $2 billion into the American economy. The announcement was made on Tuesday and includes an investment of $240 million for a Nature’s Bakery facility set to open on Wednesday in Utah, according to Fox Business.
“The over-339,000-square-foot Nature’s Bakery site will create more than 230 new jobs in the region and help the company produce nearly 1 billion bars each year, according to Mars,” the outlet reported.
“The U.S. is our biggest and most important market, and a key engine of growth for the long term – not only through our legacy manufacturing footprint but also through the expansion of strategic acquisitions like Nature’s Bakery, which is already scaling quickly,” said Mars CFO Claus Aagaard.
Over the last five years, Mars has invested over $6 billion to boost production in the U.S., including the opening of a $450 million facility in Ohio in early 2025. The facility, which produces the company’s Royal Canin animal food, created 270 new jobs.
Mars is the latest company to pledge more investment funds to the American economy, helping to fulfill President Donald Trump’s agenda and bringing more jobs and money to the United States.
“The administration previously touted that ‘Trump is on a mission to make America the manufacturing superpower of the world.’ While economist Michael Szanto believes moving more manufacturing back to the United States is a ‘worthy goal,’ he said it ‘will take time and will not be without pain,'” Fox Business reported.
More from the article:
Earlier this year, Hyundai planned to invest $20 billion to bring manufacturing operations to the U.S. followed by General Motors, which said it would invest $4 billion in its U.S. plants over the next two years to boost the manufacturing of gas and electric vehicles.
GE Aerospace announced a nearly $1 billion investment in U.S. manufacturing, while Eli Lilly announced that it was investing an additional $27 billion to boost domestic drug production, bringing the company’s total U.S. manufacturing investment to more than $50 billion since 2020.
Szanto believes that the country may face some difficulty in expanding operations, however.
“Building advanced factories like chip foundries can take years and cost billions of dollars,” he said, adding that the U.S. lacks “some of the people to even build some factories, let alone staff them.”
But it’s not all doom and gloom, says the economist.
“Our strength in manufacturing is that the United States has some of the greatest energy resources to power our factories cheaply,” he said, pointing out that”in the future, advances in automation and robotics will allow us to alleviate staffing shortages.”
Writers and editors can be contacted at [email protected] with feedback, tips, or corrections.
Sierra Marlee is a millennial whose hunger for the truth in a world of fake news has led her to write. Marlee also contributes to BizPac Review.
- Trump torches ‘sick, demented, or deranged’ lawmakers who could vote against SAVE AMERICA ACT - March 17, 2026
- Fired Trump-appointee, long-time loyalist to the president says ‘MAGA is deader than dead’ over Iran - March 17, 2026
- Mom who received guaranteed income advocates for pilot program to be permanent - March 17, 2026
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.